Gary D. Bowers

The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects

Ivy Song, Jian Zong, Julie Borland et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2016 · 121 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Human Metabolism of Lapatinib, a Dual Kinase Inhibitor: Implications for Hepatotoxicity

Stephen Castellino, Michael O'Mara, Kevin M. Koch et al. · Drug Metabolism and Disposition · 2011 · 103 citations

Medicine, Oncology, Pharmacology +17

Safety, Pharmacokinetics, and Pharmacodynamic Effects of a Selective TGR5 Agonist, SB‐756050, in Type 2 Diabetes

Rebecca J. Hodge, Lakshmi S. Vasist Johnson, Elizabeth Gould et al. · Clinical Pharmacology in Drug Development · 2013 · 73 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Disposition and metabolism of cabotegravir: a comparison of biotransformation and excretion between different species and routes of administration in humans

Gary D. Bowers, Amanda Culp, Melinda J. Reese et al. · Xenobiotica · 2015 · 52 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +15

Drug interaction profile of the HIV integrase inhibitor cabotegravir: assessment from<i>in vitro</i>studies and a clinical investigation with midazolam

Melinda J. Reese, Gary D. Bowers, Joan E. Humphreys et al. · Xenobiotica · 2015 · 49 citations

Medicine, Pharmacokinetics, Pharmacology +17